FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912385359> ?p ?o ?g. }

• W2912385359 endingPage "346" @default.
• W2912385359 startingPage "338" @default.
• W2912385359 abstract "Background The aims of this study were to explore (i) the dynamic changes in cerebral microbleeds (CMBs) in patients with symptomatic cerebral artery stenosis who received endovascular stent-assisted angioplasty and (ii) the risk factors associated with the new incidence of CMBs as well as whether CMBs increased the risk of vascular events in these patients. Methods Clinical information and magnetic resonance images were collected on admission and 3 months after endovascular stent-assisted angioplasty. Based on susceptibility-weighted imaging, the patients were divided into groups with or without newly developed CMBs, and between-group differences in risk factors were compared. We also compared whether CMBs increased the risk of vascular events among those patients. Results Seventy-three patients completed the relevant follow-up examinations. After an average follow-up period of 109 days, 7 (9.6%) patients showed new CMBs. A univariate analysis showed that the number of lacunar infarcts and the increase in systolic blood pressure were higher in patients with new CMBs than in those without new CMBs, and these differences were significant (P = 0.034, P = 0.001). Increased systolic blood pressure was an independent risk factor for developing new CMBs (P = 0.017). Conclusions CMBs may be a continuously progressing cerebral small-vessel disease. The newly developed CMBs in patients with intracranial and/or extracranial stents were associated with increased systolic blood pressure but not with the number of baseline CMBs. The aims of this study were to explore (i) the dynamic changes in cerebral microbleeds (CMBs) in patients with symptomatic cerebral artery stenosis who received endovascular stent-assisted angioplasty and (ii) the risk factors associated with the new incidence of CMBs as well as whether CMBs increased the risk of vascular events in these patients. Clinical information and magnetic resonance images were collected on admission and 3 months after endovascular stent-assisted angioplasty. Based on susceptibility-weighted imaging, the patients were divided into groups with or without newly developed CMBs, and between-group differences in risk factors were compared. We also compared whether CMBs increased the risk of vascular events among those patients. Seventy-three patients completed the relevant follow-up examinations. After an average follow-up period of 109 days, 7 (9.6%) patients showed new CMBs. A univariate analysis showed that the number of lacunar infarcts and the increase in systolic blood pressure were higher in patients with new CMBs than in those without new CMBs, and these differences were significant (P = 0.034, P = 0.001). Increased systolic blood pressure was an independent risk factor for developing new CMBs (P = 0.017). CMBs may be a continuously progressing cerebral small-vessel disease. The newly developed CMBs in patients with intracranial and/or extracranial stents were associated with increased systolic blood pressure but not with the number of baseline CMBs." @default.
• W2912385359 created "2019-02-21" @default.
• W2912385359 creator A5006095124 @default.
• W2912385359 creator A5015037416 @default.
• W2912385359 creator A5050464467 @default.
• W2912385359 creator A5057862674 @default.
• W2912385359 creator A5061386218 @default.
• W2912385359 creator A5062186132 @default.
• W2912385359 creator A5065850828 @default.
• W2912385359 creator A5076988030 @default.
• W2912385359 creator A5082678780 @default.
• W2912385359 creator A5084498174 @default.
• W2912385359 date "2019-07-01" @default.
• W2912385359 modified "2023-10-14" @default.
• W2912385359 title "A Follow-up Study of Cerebral Microbleeds in Patients Who Received Stents for Symptomatic Cerebral Artery Stenosis" @default.
• W2912385359 cites W1987361497 @default.
• W2912385359 cites W1991713272 @default.
• W2912385359 cites W1995082060 @default.
• W2912385359 cites W2005792051 @default.
• W2912385359 cites W2029676716 @default.
• W2912385359 cites W2044920476 @default.
• W2912385359 cites W2047584654 @default.
• W2912385359 cites W2053562788 @default.
• W2912385359 cites W2059157771 @default.
• W2912385359 cites W2061112002 @default.
• W2912385359 cites W2087025267 @default.
• W2912385359 cites W2091189732 @default.
• W2912385359 cites W2096420978 @default.
• W2912385359 cites W2123490970 @default.
• W2912385359 cites W2124322971 @default.
• W2912385359 cites W2129682864 @default.
• W2912385359 cites W2145109289 @default.
• W2912385359 cites W2146763492 @default.
• W2912385359 cites W2148568506 @default.
• W2912385359 cites W2164658104 @default.
• W2912385359 cites W2313988848 @default.
• W2912385359 cites W2553516233 @default.
• W2912385359 cites W2569936885 @default.
• W2912385359 cites W2572774356 @default.
• W2912385359 cites W2583393583 @default.
• W2912385359 cites W2592374523 @default.
• W2912385359 cites W2612204730 @default.
• W2912385359 cites W2613622036 @default.
• W2912385359 cites W2756430087 @default.
• W2912385359 cites W2761020194 @default.
• W2912385359 cites W2785013656 @default.
• W2912385359 cites W2790215203 @default.
• W2912385359 cites W2790248532 @default.
• W2912385359 cites W2791975082 @default.
• W2912385359 cites W2792264089 @default.
• W2912385359 cites W2802048939 @default.
• W2912385359 cites W2804976354 @default.
• W2912385359 cites W2806717648 @default.
• W2912385359 cites W2807666043 @default.
• W2912385359 cites W2975628387 @default.
• W2912385359 doi "https://doi.org/10.1016/j.avsg.2018.11.031" @default.
• W2912385359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30769077" @default.
• W2912385359 hasPublicationYear "2019" @default.
• W2912385359 type Work @default.
• W2912385359 sameAs 2912385359 @default.
• W2912385359 citedByCount "6" @default.
• W2912385359 countsByYear W29123853592020 @default.
• W2912385359 countsByYear W29123853592021 @default.
• W2912385359 countsByYear W29123853592022 @default.
• W2912385359 countsByYear W29123853592023 @default.
• W2912385359 crossrefType "journal-article" @default.
• W2912385359 hasAuthorship W2912385359A5006095124 @default.
• W2912385359 hasAuthorship W2912385359A5015037416 @default.
• W2912385359 hasAuthorship W2912385359A5050464467 @default.
• W2912385359 hasAuthorship W2912385359A5057862674 @default.
• W2912385359 hasAuthorship W2912385359A5061386218 @default.
• W2912385359 hasAuthorship W2912385359A5062186132 @default.
• W2912385359 hasAuthorship W2912385359A5065850828 @default.
• W2912385359 hasAuthorship W2912385359A5076988030 @default.
• W2912385359 hasAuthorship W2912385359A5082678780 @default.
• W2912385359 hasAuthorship W2912385359A5084498174 @default.
• W2912385359 hasConcept C120665830 @default.
• W2912385359 hasConcept C121332964 @default.
• W2912385359 hasConcept C126322002 @default.
• W2912385359 hasConcept C126838900 @default.
• W2912385359 hasConcept C143409427 @default.
• W2912385359 hasConcept C144301174 @default.
• W2912385359 hasConcept C164705383 @default.
• W2912385359 hasConcept C2778583881 @default.
• W2912385359 hasConcept C2780007028 @default.
• W2912385359 hasConcept C2780326628 @default.
• W2912385359 hasConcept C38180746 @default.
• W2912385359 hasConcept C50440223 @default.
• W2912385359 hasConcept C61511704 @default.
• W2912385359 hasConcept C71924100 @default.
• W2912385359 hasConcept C84393581 @default.
• W2912385359 hasConceptScore W2912385359C120665830 @default.
• W2912385359 hasConceptScore W2912385359C121332964 @default.
• W2912385359 hasConceptScore W2912385359C126322002 @default.
• W2912385359 hasConceptScore W2912385359C126838900 @default.
• W2912385359 hasConceptScore W2912385359C143409427 @default.
• W2912385359 hasConceptScore W2912385359C144301174 @default.
• W2912385359 hasConceptScore W2912385359C164705383 @default.

• next